BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10692750)

  • 21. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
    McAdoo MA; Rice K; Gordon GR; Sahn SA
    Clin Ther; 1998; 20(1):88-100. PubMed ID: 9522107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of cefaclor vs. amoxicillin/clavulanate in tonsillopharyngitis.
    Haczyński J; Bardadin J; Gryczyńska D; Gryczyński M; Gołabek W; Kawalski H; Kaźmierczak H; Krecicki T; Kubik P; Namysłowski G; Popiel L
    Med Sci Monit; 2001; 7(5):1016-22. PubMed ID: 11535952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cephalosporin treatment of maxillary sinusitis].
    Köhler W; Schenk P
    Laryngorhinootologie; 1995 Jun; 74(6):355-60. PubMed ID: 7662079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [5 days Cefaclor vs. 10 days amoxicillin/clavulanate in the treatment of childhood streptococcal pharyngitis. Data from a randomized clinical trial].
    Bottaro G; Biasci P; Lo Giudice M; Mele G; Montanari G; Napoleone E; Santucci A; Tucci PL; Fano M; Biraghi MG
    Minerva Pediatr; 2012 Jun; 64(3):341-6. PubMed ID: 22555328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Haczyński J; Chyczewska E; Grzelewska-Rzymowska I; Malolepszy J; Marcinkowska-Suchowierska E; Milanowski J; Oklek K; Płusa T; Słominski J; Szmygin K; Rek M
    Med Sci Monit; 2002 Jan; 8(1):PI1-7. PubMed ID: 11782685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
    Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
    J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
    Anzueto A; Niederman MS; Tillotson GS
    Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
    Brook I; Foote PA; Hausfeld JN
    Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
    Schaberg T; Ballin I; Huchon G; Bassaris H; Hampel B; Reimnitz P;
    J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.
    Langan C; Clecner B; Cazzola CM; Brambilla C; Holmes CY; Staley H
    Int J Clin Pract; 1998; 52(5):289-97. PubMed ID: 9796558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
    Kahn JB; Khashab M; Ambruzs M
    Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Baur C
    J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
    File TM; Jacobs MR; Poole MD; Wynne B;
    Int J Antimicrob Agents; 2002 Oct; 20(4):235-47. PubMed ID: 12385678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
    Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
    Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
    Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
    Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
    Gotfried MH; Ellison WT
    Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.